ISRCTN11514932未知未知
Hemolysis and cell death in conventional versus miniaturized cardiopulmonary bypass systems
Amphia Ziekenhuis0 个研究点目标入组 40 人开始时间: 2020年12月9日最近更新:
适应症
试验速览
- 阶段
- 未知
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Elective isolated CABG surgery with CPB at Amphia hospital
- •2. Male or female =18 years
- •3. The graft material used could be the: left internal mammary artery (LIMA), Right internal mammary artery (RIMA), Saphenous vein or Radial artery
排除标准
- •1. The creatinine level >150µmol/L
- •2. Aspartate transaminase (ASAT) level >80 U/L
- •3. Ejection Fraction (EF) <30%
- •4. BSA <1.6, =2.5m²
- •5. Carotid artery stenosis
- •6. Hemoglobin level <7.5, =10 mmol/L
- •7. Pre-operative red blood cell transfusion, <14 days before CABG procedure
研究者
相似试验
已完成
不适用
Erythroblasts as a parameter for mortality in critical ill patients supported with extacorporeal membrane oxygenation. A retrospective studyR57.0J80Adult respiratory distress syndromeCardiogenic shockDRKS00023626Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil GmbH30
已完成
不适用
Treatment-related mortality with Hematopoietic Stem Cell Transplantation for Progressive Systemic Sclerosis: A Systematic Review and Meta-AnalysisSystemic sclerosisJPRN-UMIN000045965Yokohama City University Graduate School of Medicine, Department of Stem Cell and Immune Regulation1,004
已完成
不适用
Hemolysis and inflammatory response to extracorporeal circulation during on-pump coronary artery bypass graft surgery: comparison between roller and centrifugal pump systemsRBR-92b9dgHospital das Clínicas da Faculdade de Medicina de Botucatu (FMB) da Universidade Estadual Paulista (Unesp)
已完成
不适用
Impact of immature haematopoetic cells on clinical risk stratification of patients with coagulation inhibitor therapycardiolgical, angiological, heart and vascular surgical interventionsDRKS00028143niversitäts-Herzzentrum Freiburg- Bad Krozingen, Campus Bad Krozingen17,835
招募中
不适用
Comparison of the frequency of acute hemolysis induced nephropathy in patients with glucose 6 phosphate dehydrogenase deficiency treated with 3 different therapeutic fluid treatmentsGlucose 6 Phosphate Dehydrogenase Deficiency.Anemia due to glucose-6-phosphate dehydrogenase [G6PD] deficiencyD55.0IRCT20090111001545N5Rasht University of Medical Sciences132